المؤلفون: Zheng Y; Clinical Pharmacology and Quantitative Pharmacology, AstraZeneca, San Francisco, CA, USA., Abuqayyas L; Clinical Pharmacology Modeling and Simulation, Amgen, Cambridge, MA, USA., Quartino A; Clinical Pharmacology and Quantitative Pharmacology, AstraZeneca, Gothenburg, Sweden., Guan Y; Clinical Pharmacology and Quantitative Pharmacology, AstraZeneca, South San Francisco, CA, USA., Gao Y; Shanghai Qiangshi Information Technology, Shanghai, China., Liu L; Shanghai Qiangshi Information Technology, Shanghai, China., Hellqvist Å; Biometrics, Late-stage Development, Respiratory and Immunology, AstraZeneca, Gothenburg, Sweden., Colice G; Late-Stage Development, Respiratory and Immunology, AstraZeneca, Gaithersburg, MD, USA., MacDonald A; Clinical Pharmacology and Quantitative Pharmacology, AstraZeneca, Cambridge, UK.

المصدر: Journal of clinical pharmacology [J Clin Pharmacol] 2024 Aug; Vol. 64 (8), pp. 908-921. Date of Electronic Publication: 2024 Apr 17.

نوع المنشور: Journal Article; Clinical Trial, Phase III

بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 0366372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4604 (Electronic) Linking ISSN: 00912700 NLM ISO Abbreviation: J Clin Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Asthma*/drug therapy , Antibodies, Monoclonal, Humanized*/pharmacokinetics , Antibodies, Monoclonal, Humanized*/administration & dosage , Antibodies, Monoclonal, Humanized*/therapeutic use , Anti-Asthmatic Agents*/pharmacokinetics , Anti-Asthmatic Agents*/administration & dosage , Anti-Asthmatic Agents*/therapeutic use , Models, Biological* , Body Weight*, Humans ; Male ; Female ; Adult ; Adolescent ; Middle Aged ; Young Adult ; Aged ; Child ; Dose-Response Relationship, Drug ; Severity of Illness Index ; Injections, Subcutaneous

المؤلفون: Aggarwal B; General Medicines, GSK, 23 Rochester Park, #06-01, GSK Asia House, Singapore, 139234, Singapore. bhumika.x.aggarwal@gsk.com., Al-Moamary M; Department of Medicine, College of Medicine, King Saudi Bin Abdulaziz University for Health Sciences, Riyadh, Kingdom of Saudi Arabia., Allehebi R; Department of Pulmonology, King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia.; College of Medicine, Alfaisal University, Riyadh, Kingdom of Saudi Arabia., Alzaabi A; Internal Medicine Department, College of Medicine and Health Sciences, UAE University, Abu Dhabi, United Arab Emirates.; Respirology Division, Zayed Military Hospital, Abu Dhabi, United Arab Emirates., Al-Ahmad M; Microbiology Department, College of Medicine, Kuwait University, Kuwait City, Kuwait., Amin M; Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Airlangga Hospital, Surabaya, Indonesia., Damayanti T; Department of Pulmonology and Respiratory Medicine, Faculty of Medicine Universitas Indonesia, Persahabatan Hospital National Respiratory Center, Jakarta, Indonesia., Van Tho N; Department of Tuberculosis and Lung Diseases, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam., Quyen PTL; Respiratory Center, Bach Mai Hospital, Hanoi, Vietnam., Sriprasart T; Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand., Poachanukoon O; Center of Excellence for Allergy, Asthma and Pulmonary Diseases and Department of Pediatrics, Thammasat University, Pathum Thani, Thailand., Yu-Lin AB; Respiratory Unit, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia., Ismail AI; Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh Campus, Selangor, Malaysia., Limpin MEB; Pulmonary and Critical Care Medicine Division, Philippine Heart Center, Quezon City, Philippines., Koenig S; St. Claire HealthCare, Morehead, KY, USA., Levy G; GSK, Panama City, Panama., Phansalkar A; GSK, Mumbai, India., Rafih F; GSK, Dubai, United Arab Emirates., Silvey M; Adelphi Real World, Bollington, UK., Miriams L; Adelphi Real World, Bollington, UK., Milligan G; Adelphi Real World, Bollington, UK.

المصدر: Advances in therapy [Adv Ther] 2024 Aug; Vol. 41 (8), pp. 3089-3118. Date of Electronic Publication: 2024 Jun 14.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther Subsets: MEDLINE

مواضيع طبية MeSH: Asthma*/drug therapy , Asthma*/therapy , Anti-Asthmatic Agents*/therapeutic use , Anti-Asthmatic Agents*/administration & dosage, Humans ; Male ; Adult ; Female ; Cross-Sectional Studies ; Middle Aged ; Malaysia ; United Arab Emirates ; Vietnam ; Saudi Arabia ; Indonesia ; Attitude of Health Personnel ; Thailand ; Philippines ; Health Knowledge, Attitudes, Practice ; Surveys and Questionnaires ; Administration, Inhalation ; Nebulizers and Vaporizers ; Medication Adherence/statistics & numerical data ; Young Adult ; Cost of Illness ; Physicians/psychology

المؤلفون: Granda P; Pharmacy Department, Hospital Central de la Defensa Gómezs Ulla, Madrid, Spain., Villamañán E; Pharmacy Department, Hospital Universitario La Paz IdiPAZ, Madrid, Spain.; Medicine Department, Universidad Autónoma de Madrid, Madrid, Spain., Carpio C; Medicine Department, Universidad Autónoma de Madrid, Madrid, Spain.; Pneumology Department, Hospital Universitario La Paz IdiPAZ, Madrid, Spain., Laorden D; Pneumology Department, Hospital Universitario La Paz IdiPAZ, Madrid, Spain., Quirce S; Allergy Department, Hospital Universitario La Paz. IdiPAZ, Madrid, Spain., Álvarez-Sala R; Medicine Department, Universidad Autónoma de Madrid, Madrid, Spain.; Pneumology Department, Hospital Universitario La Paz IdiPAZ, Madrid, Spain.

مؤلفون مشاركون: NEUMO Study Group

المصدر: The Journal of asthma : official journal of the Association for the Care of Asthma [J Asthma] 2024 Aug; Vol. 61 (8), pp. 857-866. Date of Electronic Publication: 2024 Feb 09.

نوع المنشور: Journal Article; Multicenter Study; Comparative Study

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8106454 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-4303 (Electronic) Linking ISSN: 02770903 NLM ISO Abbreviation: J Asthma Subsets: MEDLINE

مواضيع طبية MeSH: Asthma*/drug therapy , Asthma*/physiopathology , Interleukin-5*/antagonists & inhibitors , Anti-Asthmatic Agents*/therapeutic use , Anti-Asthmatic Agents*/administration & dosage , Antibodies, Monoclonal, Humanized*/therapeutic use , Antibodies, Monoclonal, Humanized*/administration & dosage, Humans ; Retrospective Studies ; Male ; Female ; Middle Aged ; Adult ; Severity of Illness Index ; Biological Products/therapeutic use ; Biological Products/administration & dosage ; Aged ; Respiratory Function Tests ; Eosinophils/immunology ; Interleukin-5 Receptor alpha Subunit/antagonists & inhibitors ; Hospitalization/statistics & numerical data

المؤلفون: Lim YT; Department of Paediatric Respiratory, Royal Hospital for Children, Glasgow, UK., Williams TC; Department of Paediatric Respiratory, Royal Hospital for Children, Glasgow, UK., Langley RJ; Department of Paediatric Respiratory, Royal Hospital for Children, Glasgow, UK., Weir E; Department of Paediatric Respiratory, Royal Hospital for Children, Glasgow, UK.

المصدر: The Journal of asthma : official journal of the Association for the Care of Asthma [J Asthma] 2024 Aug; Vol. 61 (8), pp. 793-800. Date of Electronic Publication: 2024 Jan 24.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8106454 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-4303 (Electronic) Linking ISSN: 02770903 NLM ISO Abbreviation: J Asthma Subsets: MEDLINE

مواضيع طبية MeSH: Asthma*/drug therapy , Asthma*/physiopathology , Antibodies, Monoclonal, Humanized*/administration & dosage , Antibodies, Monoclonal, Humanized*/therapeutic use , Anti-Asthmatic Agents*/therapeutic use , Anti-Asthmatic Agents*/administration & dosage, Humans ; Male ; Child ; Female ; Adolescent ; Retrospective Studies ; Eosinophils/immunology ; Leukocyte Count ; Hospitalization/statistics & numerical data ; Omalizumab/therapeutic use ; Omalizumab/administration & dosage ; Forced Expiratory Volume/drug effects ; Severity of Illness Index ; Adrenal Cortex Hormones/therapeutic use ; Adrenal Cortex Hormones/administration & dosage ; Pulmonary Eosinophilia/drug therapy

المؤلفون: Ho AVL; College of Medicine and Dentistry, James Cook University, Cairns, QLD 4878, Australia., Lau I; College of Medicine and Dentistry, James Cook University, Cairns, QLD 4878, Australia., Davidson M; College of Medicine and Dentistry, James Cook University, Cairns, QLD 4878, Australia., Nimmo A; College of Medicine and Dentistry, James Cook University, Cairns, QLD 4878, Australia., Croker FA; College of Medicine and Dentistry, James Cook University, Cairns, QLD 4878, Australia.

المصدر: The International journal of pharmacy practice [Int J Pharm Pract] 2024 Jul 04; Vol. 32 (4), pp. 280-286.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 9204243 Publication Model: Print Cited Medium: Internet ISSN: 2042-7174 (Electronic) Linking ISSN: 09617671 NLM ISO Abbreviation: Int J Pharm Pract Subsets: MEDLINE

مواضيع طبية MeSH: Pharmacists*/organization & administration , Asthma*/drug therapy , Community Pharmacy Services*/organization & administration , Anti-Asthmatic Agents*/administration & dosage , Anti-Asthmatic Agents*/adverse effects , Professional Role* , Oral Health* , Health Knowledge, Attitudes, Practice*, Humans ; Surveys and Questionnaires ; Male ; Female ; Attitude of Health Personnel ; Queensland ; Adult ; Middle Aged

المؤلفون: Kobayashi N; Department of Pulmonology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan. nkobayas@yokohama-cu.ac.jp., Matsumoto H; Department of Pulmonology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan., Somekawa K; Department of Pulmonology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan., Kaneko A; Department of Pulmonology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan., Fukuda N; Department of Pulmonology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan., Muraoka S; Department of Pulmonology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan., Ohtsu Y; Department of Pulmonology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan., Hirata M; Department of Pulmonology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan., Nagasawa R; Department of Pulmonology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan., Kubo S; Department of Pulmonology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan., Murohashi K; Department of Pulmonology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan., Fujii H; Department of Pulmonology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan., Aoki A; Department of Pulmonology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan., Watanabe K; Department of Pulmonology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan., Horita N; Department of Pulmonology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan., Hara Y; Department of Pulmonology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan., Kaneko T; Department of Pulmonology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan.

المصدر: Scientific reports [Sci Rep] 2024 Jul 02; Vol. 14 (1), pp. 15190. Date of Electronic Publication: 2024 Jul 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Asthma*/drug therapy , Asthma*/economics , Antibodies, Monoclonal, Humanized*/therapeutic use , Antibodies, Monoclonal, Humanized*/economics , Anti-Asthmatic Agents*/therapeutic use , Anti-Asthmatic Agents*/economics, Humans ; Japan ; Male ; Female ; Middle Aged ; Adult ; Aged ; Practice Patterns, Physicians'

المؤلفون: Apata J; Division of Epidemiology, US Food and Drug Administration Center for Drug Evaluation and Research, Silver Spring, MD, USA., Lyons JG; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA., Bradley MC; Division of Epidemiology, US Food and Drug Administration Center for Drug Evaluation and Research, Silver Spring, MD, USA., Ma Y; Division of Biometrics, US Food and Drug Administration Center for Drug Evaluation and Research, Silver Spring, MD, USA., Kempner ME; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA., Kim I; Division of Pharmacovigilance, US Food and Drug Administration Center for Drug Evaluation and Research, Silver Spring, MD, USA., Eworuke E; Formerly at Division of Epidemiology, US Food and Drug Administration Center for Drug Evaluation and Research, Silver Spring, MD, USA., Pennap D; Formerly at Division of Epidemiology, US Food and Drug Administration Center for Drug Evaluation and Research, Silver Spring, MD, USA., Mosholder A; Division of Epidemiology, US Food and Drug Administration Center for Drug Evaluation and Research, Silver Spring, MD, USA.

المصدر: The Journal of asthma : official journal of the Association for the Care of Asthma [J Asthma] 2024 Jul; Vol. 61 (7), pp. 653-662. Date of Electronic Publication: 2023 Dec 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8106454 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-4303 (Electronic) Linking ISSN: 02770903 NLM ISO Abbreviation: J Asthma Subsets: MEDLINE

مواضيع طبية MeSH: Acetates*/adverse effects , Acetates*/administration & dosage , Acetates*/therapeutic use , International Classification of Diseases* , Cyclopropanes* , Sulfides* , Quinolines*/adverse effects , Quinolines*/administration & dosage , Asthma*/drug therapy , Self-Injurious Behavior*/epidemiology , Self-Injurious Behavior*/chemically induced , Anti-Asthmatic Agents*/adverse effects , Anti-Asthmatic Agents*/administration & dosage , Anti-Asthmatic Agents*/therapeutic use, Humans ; Male ; Female ; Adult ; Middle Aged ; Adolescent ; Child ; Young Adult ; Suicide, Attempted/statistics & numerical data ; Aged ; Cohort Studies ; Risk Assessment/methods ; Adrenal Cortex Hormones/administration & dosage ; Adrenal Cortex Hormones/adverse effects ; Adrenal Cortex Hormones/therapeutic use

المؤلفون: Beasley R; Medical Research Institute of New Zealand, Wellington, New Zealand Richard.Beasley@mrinz.ac.nz., Noble J; Medical Research Institute of New Zealand, Wellington, New Zealand., Weatherall M; University of Otago Wellington, Wellington, New Zealand.

المصدر: The European respiratory journal [Eur Respir J] 2024 Jun 20; Vol. 63 (6). Date of Electronic Publication: 2024 Jun 20 (Print Publication: 2024).

نوع المنشور: Editorial; Letter; Comment

بيانات الدورية: Publisher: European Respiratory Society Country of Publication: England NLM ID: 8803460 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1399-3003 (Electronic) Linking ISSN: 09031936 NLM ISO Abbreviation: Eur Respir J Subsets: MEDLINE

مواضيع طبية MeSH: Asthma*/drug therapy , Formoterol Fumarate*/administration & dosage , Formoterol Fumarate*/therapeutic use , Anti-Asthmatic Agents*/therapeutic use , Anti-Asthmatic Agents*/administration & dosage , Ethanolamines*/therapeutic use , Ethanolamines*/administration & dosage, Humans ; Adrenal Cortex Hormones/administration & dosage ; Adrenal Cortex Hormones/therapeutic use ; Administration, Inhalation ; Evidence-Based Medicine ; Bronchodilator Agents/therapeutic use ; Bronchodilator Agents/administration & dosage ; Treatment Outcome

المؤلفون: Salerni C; Respiratory Unit, ASST Santi Paolo e Carlo, San Paolo Hospital, Department of Health Sciences, University of Milan, Milan, Italy., Baccelli A; Respiratory Unit, ASST Santi Paolo e Carlo, San Paolo Hospital, Department of Health Sciences, University of Milan, Milan, Italy., Parazzini EM; Respiratory Unit, ASST Santi Paolo e Carlo, San Paolo Hospital, Department of Health Sciences, University of Milan, Milan, Italy., Rinaldo R; Respiratory Unit, ASST Valle Olona, Busto Arsizio, Italy., Centanni S; Respiratory Unit, ASST Santi Paolo e Carlo, San Paolo Hospital, Department of Health Sciences, University of Milan, Milan, Italy.

المصدر: The Journal of asthma : official journal of the Association for the Care of Asthma [J Asthma] 2024 Jun; Vol. 61 (6), pp. 649-652. Date of Electronic Publication: 2023 Dec 21.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8106454 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-4303 (Electronic) Linking ISSN: 02770903 NLM ISO Abbreviation: J Asthma Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized*/therapeutic use , Antibodies, Monoclonal, Humanized*/adverse effects , Antibodies, Monoclonal, Humanized*/administration & dosage , Headache*/drug therapy , Headache*/chemically induced , Asthma*/drug therapy , Anti-Asthmatic Agents*/adverse effects , Anti-Asthmatic Agents*/therapeutic use , Anti-Asthmatic Agents*/administration & dosage, Humans ; Male ; Middle Aged ; Adrenal Cortex Hormones/therapeutic use ; Adrenal Cortex Hormones/administration & dosage

المؤلفون: Bozek A; Clinical Department of Internal Diseases, Dermatology and Allergology, Medical University of Silesia, Katowice, Poland., Rogala B; Medical University of Silesia, Katowice, Poland., Miodonska M; Clinical Department of Internal Diseases, Dermatology and Allergology, Medical University of Silesia, Katowice, Poland., Canonica GW; Head Personalized Medicine Asthma & Allergy Clinic-Humanitas, Research Hospital, Humanitas University, Milano, Italy.

المصدر: The Journal of asthma : official journal of the Association for the Care of Asthma [J Asthma] 2024 Jun; Vol. 61 (6), pp. 532-538. Date of Electronic Publication: 2023 Dec 27.

نوع المنشور: Journal Article; Randomized Controlled Trial; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8106454 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-4303 (Electronic) Linking ISSN: 02770903 NLM ISO Abbreviation: J Asthma Subsets: MEDLINE

مواضيع طبية MeSH: Omalizumab*/therapeutic use , Omalizumab*/administration & dosage , Asthma*/immunology , Asthma*/drug therapy , Asthma*/therapy , Desensitization, Immunologic*/methods , Pyroglyphidae*/immunology , Anti-Asthmatic Agents*/therapeutic use , Anti-Asthmatic Agents*/administration & dosage, Humans ; Male ; Female ; Adult ; Middle Aged ; Animals ; Treatment Outcome ; Adolescent ; Young Adult ; Double-Blind Method